Panel Discussion: What Will it Take to Standardize Spatial Across Industry & Who Should Lead the Charge?
Time: 10:30 am
day: Day One
Details:
- What are the most critical barriers currently preventing standardization across spatial platforms, workflows, and datasets in biopharma?
- How do inconsistent tissue handling, assay protocols, and data formats affect cross-study comparability and regulatory acceptance?
- Should standardization start with biomarkers, instrumentation, data pipelines, or all at once? What should the priority be?
